Skin Laboratory PCL (BKK:SKIN) Scaled Net Operating Assets: 0.24 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SKIN Skin Laboratory PCL BKK:SKIN
20 GF Score
Price ฿0.88
! 2 Warning Signs
View Full Analysis

What is Skin Laboratory PCL Scaled Net Operating Assets?

Skin Laboratory PCL BKK:SKIN +3.53% 20 Scaled Net Operating Assets is 0.24 as of Mar. 2026. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Skin Laboratory PCL's operating assets for the quarter that ended in Mar. 2026 was ฿48.6 Mil. Skin Laboratory PCL's operating liabilities for the quarter that ended in Mar. 2026 was ฿19.1 Mil. Skin Laboratory PCL's Total Assets for the quarter that ended in Dec. 2025 was ฿123.5 Mil. Therefore, Skin Laboratory PCL's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.24.


Skin Laboratory PCL Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Skin Laboratory PCL's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Laboratory PCL Scaled Net Operating Assets Chart

Skin Laboratory PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
0.38 0.30 0.35 0.36

Skin Laboratory PCL Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 0.00 0.26 0.24

BKK:SKIN vs PG, CL, KVUE: Scaled Net Operating Assets Comparison

For the Household & Personal Products subindustry, Skin Laboratory PCL's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skin Laboratory PCL Scaled Net Operating Assets vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Skin Laboratory PCL's Scaled Net Operating Assets falls into.


BKK:SKIN
20GF Score
Skin Laboratory PCL BKK:SKIN
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skin Laboratory PCL Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Skin Laboratory PCL's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(51.168-20.895)/85.146
=0.36

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=123.529 - 72.361
=51.168

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=22.341 - 0.115 - 1.331
=20.895

Skin Laboratory PCL's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(48.641-19.073)/123.529
=0.24

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=113.61 - 64.969
=48.641

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=20.195 - 0 - 1.122
=19.073

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.24 mean?
Skin Laboratory PCL (BKK:SKIN) has a Scaled Net Operating Assets of 0.24 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Skin Laboratory PCL and its competitors.
Is Skin Laboratory PCL's Scaled Net Operating Assets too high?
Skin Laboratory PCL's current Scaled Net Operating Assets is 0.24. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's Scaled Net Operating Assets compare to PG and CL?
Skin Laboratory PCL's Scaled Net Operating Assets of 0.24 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Consumer Packaged Goods company?
A good Scaled Net Operating Assets depends on the Consumer Packaged Goods industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Skin Laboratory PCL and its competitors. Skin Laboratory PCL's current Scaled Net Operating Assets is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current Scaled Net Operating Assets of 0.24. The current Scaled Net Operating Assets is 0.24. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current Scaled Net Operating Assets is 0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Laboratory PCL Business Description

Address Unit P, Popular Road, No. 89, Cosmo Office Park Building, 8th Floor, Ban Mai Subdistrict, Pak Kret District, Nonthaburi, THA, 11120
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score

Get the complete analysis for BKK:SKIN

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.88
Price